Inflammatix, a pioneering molecular diagnostics company, today announced initiation of the TriVeritytm for Improved Management of Emergency Department Patients with Suspected Infections Trial (the ...
The funding will drive Nexstem to scale operations for its latest product - Instinct Ecosystem, enhance its IP portfolio and presence in American and European marketsThe capital will accelerate the de ...